Research study Program year 2021 Source: CMS Open Payments

ABP 938 Global Phase 3 Study

Research payments

$3,470,701

163 payments

Through program year 2021, $3,470,701 in research payments was reported against ABP 938 Global Phase 3 Study, across 163 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$2,833,239	96
2020	Research	$637,462	67

Breakdown

Who paid Research payments · program years 2020–2021

Amgen Inc. $3,470,701 163 payments

Who received the money Research payments · program years 2020–2021

Texas Retina Associates Organisation paid for research $266,652 11 payments
Retina Center Of Grass Valley, INC Organisation paid for research $224,869 3 payments
Retina Vitreous Surgeons Of Central New York, Pc Organisation paid for research $182,915 3 payments
Medeye Associates Organisation paid for research $163,444 4 payments
Retina Research Institute Of Texas Organisation paid for research $148,492 4 payments
Black Hills Regional Eye Institute, LLP Organisation paid for research $147,357 2 payments
Florida Retina Consultants Organisation paid for research $123,084 3 payments
Strategic Clinical Research Group LLC Organisation paid for research $115,557 2 payments
Southeast Retina Center, Pc Organisation paid for research $115,124 5 payments
Retina Consultants San Diego Organisation paid for research $110,883 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.